These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8410386)

  • 41. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Acute renal failure caused by indomethacin overdose in a premature infant with patent ductus arteriosus].
    Winter A; Tapia JL; Ventura-Juncá P; Juez G; Rivera W
    Rev Chil Pediatr; 1986; 57(5):444-6. PubMed ID: 3616022
    [No Abstract]   [Full Text] [Related]  

  • 43. New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure.
    Attridge JT; Clark R; Walker MW; Gordon PV
    J Perinatol; 2006 Feb; 26(2):93-9. PubMed ID: 16319937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized trial of sterile water by gavage drip in the fluid management of extremely low birth weight infants.
    Stewart CD; Morris BH; Huseby V; Kennedy KA; Moya FR
    J Perinatol; 2009 Jan; 29(1):26-32. PubMed ID: 18754014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Indomethacin for patent ductus arteriosus.
    Med Lett Drugs Ther; 1981 Oct; 23(22):95-6. PubMed ID: 7289976
    [No Abstract]   [Full Text] [Related]  

  • 46. [Pseudo-"isolated" intestinal perforation in a very low birth weight infant: exceptional presentation of Hirschsprung's disease].
    Courvoisier S; Piolat C; Durand C; Cneude F; Andrini P; Jacquier C; Debillon T; Dyon JF
    Arch Pediatr; 2006 Oct; 13(10):1320-2. PubMed ID: 16919428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New insights into spontaneous intestinal perforation using a national data set: (2) two populations of patients with perforations.
    Attridge JT; Clark R; Walker MW; Gordon PV
    J Perinatol; 2006 Mar; 26(3):185-8. PubMed ID: 16493433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Closure of ductus arteriosus by drug therapy and indomethacin dosage].
    Kertész E; Polgár M; Kemény J; Szirmai Z
    Orv Hetil; 1980 Mar; 121(12):735-6. PubMed ID: 7383650
    [No Abstract]   [Full Text] [Related]  

  • 49. Gastric perforation associated with indomethacin therapy in a pre-term infant.
    Gray PH; Pemberton PJ
    Aust Paediatr J; 1980 Mar; 16(1):65-6. PubMed ID: 7387564
    [No Abstract]   [Full Text] [Related]  

  • 50. Prophylactic indomethacin: factors determining permanent ductus arteriosus closure.
    Narayanan M; Cooper B; Weiss H; Clyman RI
    J Pediatr; 2000 Mar; 136(3):330-7. PubMed ID: 10700689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less.
    Koch J; Hensley G; Roy L; Brown S; Ramaciotti C; Rosenfeld CR
    Pediatrics; 2006 Apr; 117(4):1113-21. PubMed ID: 16585305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Spontaneous intestinal perforation in newborn infants. A form of necrotizing enterocolitis].
    Aldana-Valenzuela C; Mannino FL
    Bol Med Hosp Infant Mex; 1989 Jan; 46(1):30-4. PubMed ID: 2713046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A rare cause of intestinal perforation in an extreme low birth weight infant--gastrointestinal mucormycosis: a case report.
    Siu KL; Lee WH
    J Perinatol; 2004 May; 24(5):319-21. PubMed ID: 15116129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Indomethacin-associated bowel perforations: a study of possible risk factors.
    Shorter NA; Liu JY; Mooney DP; Harmon BJ
    J Pediatr Surg; 1999 Mar; 34(3):442-4. PubMed ID: 10211650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Indomethacin-induced ileal perforation].
    Baldonedo Cernuda RF; Alvarez Pérez JA; García Bear I; Truán Alonso N; Jorge Barreiro JI
    Gastroenterol Hepatol; 2004 Jan; 27(1):18-20. PubMed ID: 14718104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The management of patient ductus arteriosus in very low birthweight infants.
    Yu VY; Knight DB; Obeyesekere HI; Mitvalsky J
    J Singapore Paediatr Soc; 1983; 25(3-4):159-66. PubMed ID: 6678365
    [No Abstract]   [Full Text] [Related]  

  • 57. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
    Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
    Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus.
    Fanos V; Benini D; Verlato G; Errico G; Cuzzolin L
    Fundam Clin Pharmacol; 2005 Apr; 19(2):187-93. PubMed ID: 15810899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Criteria for use of indomethacin injection in neonates.
    Renfro WH; Burr JM; Rawlings J
    Clin Pharm; 1993 Mar; 12(3):232-4. PubMed ID: 8491081
    [No Abstract]   [Full Text] [Related]  

  • 60. Segmental absence of intestinal musculature: an increasingly reported pathology.
    Davis JS; Ryan ML; Shields JM; Sola JE; Perez EA; Neville HL; Rodriguez MM
    J Pediatr Surg; 2012 Aug; 47(8):1566-71. PubMed ID: 22901918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.